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Gene Therapy: A Novel Approach to 
Leukemia Treatment
Purpose
•Lay out current methods of leukemia treatment
•Examine gene therapy as a treatment method 
•Discuss the nursing role in gene therapy for leukemia
Background
• Leukemia is the 10th leading cause of death worldwide. 
• Leukemia has been traditionally treated with 
chemotherapy. 
• Gene therapy uses genetic vectors to correct gene 
mutations.
• Nurses  are at the front line of integrating genetics and 
genomics patient response research.
Methods
The CINAHL and OVID Medline databases were utilized to 
determine the relations between leukemia 
diagnosis/prognosis, chemotherapeutic treatments, and 
genetic therapy in nursing care of patients.
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Findings
Leukemia Types
• Most common types: Acute Myeloid (AML), Chronic     
Myeloid (CML), Acute Lymphocytic (ALL), Chronic 
Lymphocytic (CLL)
• Leukemia involves un-proliferated cell growth and bone 
marrow disruption.
Current Leukemia Treatments
• Current treatment: two-step chemotherapy
• Induction: target malignant cells
• Consolidation: prolong remission 
• Chemotherapeutic cure rates in AML
• 20% – 75% 
• 60+: <10%
• Chemotherapeutic cure rates in ALL
• Children: 70% - 80% 
• Adults: 40% 
• Also have acute and long-term side effects
Gene Therapy
• Gene therapy targets genetic abnormalities to control 
malignant cell growth. 
• Includes enzymatic inhibitors targeting genetic mutations 
in specific T-cells. 
• The major agent for CML is imatinib mesylate.
• AML is currently being treated with a regimen of 
cytarabine, anthracycline, vorinostat, and a histone 
decetylase inhibitor. 
• FLT3 gene also being targeted
o Initial results are promising, but further research 
is needed.
Discussion
Limitations of Gene Therapy
• Potential for discrimination based on genetic tendencies 
toward leukemia. 
• Other issues
• Methods of acquiring genetic information
• Privacy of genetic test results
• Knowledge of healthcare professionals in regards to
gene therapy
• Psychosocial impact of knowing genetic test results. 
Nursing Role
• Nurses are to educate themselves on gene therapy and 
delivering information to their patients.
• Nurses have responsibilities to their patients at each stage.
• Pre-diagnostic stage: limit modifiable risk factors
• Diagnostic stage: educate patients about leukemia and 
answer questions
• Treatment stage: explain treatment plans and offer 
coping resources
• Terminal stage: provide palliative care 
Conclusion
While chemotherapy has been a fairly consistent leukameic
treatment, gene therapy has the potential to tailor treatment 
based on individual genetic makeup and thus meet with 
higher cure rates overall than chemotherapy.
Future Directions
• Nurses to educate themselves on genetic therapies and 
incorporating these into patient care.
• Nurse scientists and advance practice nurses to undergo 
education on molecular genetics. 
• Future studies
• Alteration of genes in utero in order to decrease cancer 
risk prevention techniques 
• Genetic screening for vulnerable individuals
• Longer-term results of genetic therapy
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